Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency drugs in development, 2024

GlobalData tracks 6 drugs in development for Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency by six companies/universities/institutes. The top development phase for Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency is phase ii, with three drugs in that stage.

ActiGraph executives on why getting digital endpoints approved for drug trials matters

As drugmakers wade into using digital health technologies, ActiGraph has made its mission to become the wearable of choice for the industry. The Pensacola, Fla.-based

August 17, 2023

Triglycerides Down With ANGPTL3 RNA Interference Agent

An RNA interference therapy, targeting ANGPTL3 in the liver, drastically reduced fasting triglycerides in people with mixed hyperlipidemia, the ARCHES-2 trial showed. Used atop usual

May 30, 2024

How to Position the Growing Number of Therapies in IBD

At the American College of Gastroenterology (ACG) annual meeting, Miguel Regueiro, MD, of the Digestive Disease and Surgery Institute at the Cleveland Clinic, discussed the

November 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.